RAPCELDA Trademark

Trademark Overview

On Monday, April 2, 2018, a trademark application was filed for RAPCELDA with the United States Patent and Trademark Office. The USPTO has given the RAPCELDA trademark a serial number of 87859164. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Stemline Therapeutics, Inc.. The RAPCELDA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agents in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases; diagnostic reagents for medicinal use, namely, for the diagnosis and treatment of cancer and auto-immune diseases
rapcelda

General Information

Serial Number87859164
Word MarkRAPCELDA
Filing DateMonday, April 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agents in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases; diagnostic reagents for medicinal use, namely, for the diagnosis and treatment of cancer and auto-immune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStemline Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameStemline Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 23, 2021SOU EXTENSION 5 GRANTED
Tuesday, September 21, 2021SOU EXTENSION 5 FILED
Thursday, September 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 21, 2021SOU TEAS EXTENSION RECEIVED
Friday, March 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 24, 2021SOU EXTENSION 4 GRANTED
Wednesday, March 24, 2021SOU EXTENSION 4 FILED
Wednesday, March 24, 2021SOU TEAS EXTENSION RECEIVED
Thursday, October 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2020SOU EXTENSION 3 GRANTED
Tuesday, October 6, 2020SOU EXTENSION 3 FILED
Tuesday, October 6, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 4, 2020SOU EXTENSION 2 GRANTED
Saturday, April 4, 2020SOU EXTENSION 2 FILED
Saturday, April 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, October 6, 2019SOU EXTENSION 1 GRANTED
Sunday, October 6, 2019SOU EXTENSION 1 FILED
Sunday, October 6, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 7, 2019ASSIGNED TO LIE
Wednesday, December 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 3, 2018ASSIGNED TO EXAMINER
Monday, April 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 5, 2018NEW APPLICATION ENTERED

Related Keywords

rapcelda immune diseases cancer auto treatment diagnosis diagnostic reagents namely infusion